Saneca Pharmaceuticals stock traded at EUR 20.3 per share at the end 2019 translating into a market capitalization of USD 22.8 mil. Since the end of 2014, the stock has appreciated by 0% representing an annual average growth of %.
At the end of 2019, the firm traded at price to earnings of -5.64x. Over the last five years, this multiple achieved a high of -5.64x in 2019 and a low of -5.64x in 2019 with an average of -5.64x.
Regarding cash generated defined by the sum of net profit and depreciation, the stock traded at -10.5x at the end of 2019. When investments are excluded to get free cash flow, Saneca Pharmaceuticals traded at -4.82x.
At the end of 2019, the company had a net debt of EUR 8.68 mil, or -5.20x of EBITDA and 35.7% of equity. The firm generated an average return on equity of -7.39% for its shareholders in the last five years and an average dividend yield of 0%.
You can see all the company’s data at Saneca Pharmaceuticals profile, or you can download a report on the company in the report section.
Helgi Library 
